Homelife sciences

life sciences

Curis Announces Closing of Public Offering of Common Stock with $169.6 Million in Gross Proceeds, Including Full Exercise of Underwriters’ Option to Purchase Additional Shares

Curis Announces Closing of Public Offering of Common Stock with $169.6 Million in Gross Proceeds, Including Full Exercise of Underwriters’ Option to Purchase Additional Shares

December 14, 2020

Caladrius Biosciences Provides Year-End 2020 Strategic Portfolio Update

Caladrius Biosciences Provides Year-End 2020 Strategic Portfolio Update

December 14, 2020

AnPac Bio Makes Significant Progress in Detecting Pre-cancer Diseases and Recorded Over 20 Types of Pre-cancer Diseases

AnPac Bio Makes Significant Progress in Detecting Pre-cancer Diseases and Recorded Over 20 Types of Pre-cancer Diseases

December 14, 2020

Hepion Pharmaceuticals (HEPA) Jumps: Stock Rises 9%

Hepion Pharmaceuticals (HEPA) Jumps: Stock Rises 9%

December 11, 2020

Akari Therapeutics Reports Third Quarter 2020 Financial Results and Highlights Recent Clinical Progress

Akari Therapeutics Reports Third Quarter 2020 Financial Results and Highlights Recent Clinical Progress

December 11, 2020

Akari Therapeutics Announces New Clinical Data that Show Long-Term Self-Administered Nomacopan is Well-Tolerated and Substantially Reduces Transfusion Dependence in Patients with Paroxysmal Nocturnal Hemoglobinuria (PNH)

Akari Therapeutics Announces New Clinical Data that Show Long-Term Self-Administered Nomacopan is Well-Tolerated and Substantially Reduces Transfusion Dependence in Patients with Paroxysmal Nocturnal Hemoglobinuria (PNH)

December 11, 2020

Galectin Therapeutics, Inc. to Present at the 4th Annual Digital NASH Summit on December 17, 2020

Galectin Therapeutics, Inc. to Present at the 4th Annual Digital NASH Summit on December 17, 2020

December 11, 2020

Nabriva Therapeutics Announces Pricing of $15 Million Public Offering

Nabriva Therapeutics Announces Pricing of $15 Million Public Offering

December 10, 2020

XOMA Prices $22 Million Offering of Series A Cumulative Perpetual Preferred Stock

XOMA Prices $22 Million Offering of Series A Cumulative Perpetual Preferred Stock

December 10, 2020

ERYTECH to Present at the JMP Securities Hematology Summit

ERYTECH to Present at the JMP Securities Hematology Summit

December 10, 2020

« 1 … 549 550 551 552 553 … 557 »